Nerelimomab: Difference between revisions
Content deleted Content added
Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'CAS_number'). |
Entranced98 (talk | contribs) Adding local short description: "Monoclonal antibody", overriding Wikidata description "chemical compound" |
||
| (7 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
| ⚫ | |||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
| Verifiedfields = changed |
||
| verifiedrevid = |
| verifiedrevid = 458282962 |
||
| image = |
| image = |
||
<!-- Monoclonal antibody data --> |
|||
| ⚫ | |||
| type = mab |
| type = mab |
||
| mab_type = mab |
| mab_type = mab |
||
| source = o |
| source = o |
||
| target = [[TNF alpha]] |
| target = [[TNF alpha]] |
||
| ⚫ | |||
| ⚫ | |||
| tradename = |
| tradename = |
||
| pregnancy_AU = |
| pregnancy_AU = |
||
| Line 21: | Line 20: | ||
| legal_status = |
| legal_status = |
||
| routes_of_administration = |
| routes_of_administration = |
||
| ⚫ | |||
| ⚫ | |||
| bioavailability = |
| bioavailability = |
||
| protein_bound = |
| protein_bound = |
||
| Line 28: | Line 26: | ||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| ⚫ | |||
| UNII = 1911H0X9KJ |
|||
| ATC_prefix = none |
| ATC_prefix = none |
||
| ATC_suffix = |
| ATC_suffix = |
||
| Line 40: | Line 39: | ||
| KEGG = D05146 |
| KEGG = D05146 |
||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
||
| ChemSpiderID = |
| ChemSpiderID = none |
||
| ⚫ | |||
| ⚫ | |||
| chemical_formula = |
| chemical_formula = |
||
| molecular_weight = |
| molecular_weight = |
||
}} |
}} |
||
'''Nerelimomab''' is a [[mouse]] [[monoclonal antibody]] acting as a [[TNF inhibitor]].<ref> |
'''Nerelimomab''' is a [[mouse]] [[monoclonal antibody]] acting as a [[TNF inhibitor]].<ref>{{Cite web |url=http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list76.pdf |title=WHO Drug Information |access-date=2009-09-24 |archive-url=https://web.archive.org/web/20120219143254/http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list76.pdf |archive-date=2012-02-19 |url-status=dead }}</ref> |
||
==References== |
==References== |
||
| Line 55: | Line 52: | ||
{{immunosuppressants}} |
{{immunosuppressants}} |
||
{{Monoclonals for immune system}} |
{{Monoclonals for immune system}} |
||
[[Category:Monoclonal antibodies]] |
|||